SCHEMBL3656313

SCHEMBL3656313

O=C(O)c1cc(CC(O)(F)F)cc(-c2ccc(F)cc2F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
DHFR P00374 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
LMNA P02545 1/20 0.44
ALB P02768 1/20 0.44
HMGB1 P09429 1/20 0.44
HPGD P15428 1/20 0.44
CXCL12 P48061 1/20 0.44
KMT2A Q03164 1/20 0.44
HIF1A Q16665 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
ACMSD Q8TDX5 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PTGER1 P34995 2/20 0.39
AKR1C3 P42330 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3801494 0.83 APP (0.38) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL475505 0.81 TTR (0.57) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL19325888 0.79 IDO1 (0.45) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL19320830 0.79 PTGER1 (0.44) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL3657877 0.78 AKR1C3 (0.43) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL3071028 0.76 TTR (0.46) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL21711610 0.74 MRGPRX4 (0.47) KMT2APTGER1AKR1C3MRGPRX4AKR1C2
SCHEMBL411705 0.72 BCL2L1 (0.62) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL16195147 0.71 DHODH (0.51) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL475628 0.71 ALPL (0.51) TTRKDM4EMEN1USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215049-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN Merck Sharp & Dohme Corp. (US) 2010-08-11 EP disclosed
WO-2009058298-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK & CO., INC. (US) 2009-05-07 WO disclosed